Andrew S. Davis - 20 May 2022 Form 4 Insider Report for Silk Road Medical Inc

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
20 May 2022
Net transactions value
+$10,872
Form type
4
Filing time
07 Jul 2022, 16:29:57 UTC
Previous filing
04 Mar 2022
Next filing
04 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Tax liability $2,608 -69 -0.07% $37.80 103,711 05 Jul 2022 Direct F1
transaction SILK Common Stock Award $13,480 +550 +0.53% $24.51 104,261 20 May 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
F2 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).